3 completed. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Lung Infection: new trials by email Literature Review of Lung Infection trials Research Report on Lung Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia Opaganib, Placebo - COVID-19, Lung Infection | Phase 2 / Phase 3 | Completed | RedHill Biopharma Limited | 475 | 2020-08-21 | 2025-07-31 |
| Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301 AR-301, Placebo - Lung Infection, Pneumonia, Ventilator-Associated | Phase 3 | Completed | Aridis Pharmaceuticals, Inc. | 174 | 2019-05-03 | 2023-07-06 |
| Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa AZLI 75 mg three times daily (TID), Placebo three times daily (TID) - Cystic Fibrosis, Lung Infection | Phase 3 | Completed | Gilead Sciences | 160 | 2008-05-01 | 2010-12-20 |
Bacterial Infections (1) · COVID-19 (1) · Cystic Fibrosis (1) · Infections (1) · Pneumonia (1) · Pneumonia, Ventilator-Associated (1) · Pseudomonas Infections (1) · Staphylococcal Infections (1)
Lung Diseases (3) · Respiratory Tract Diseases (3) · Bacterial Infections and Mycoses (2) · Infections (2) · Respiratory Tract Infections (2) · Bacterial Infections (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Cross Infection (1) · Digestive System Diseases (1) · Disease Attributes (1) · Genetic Diseases, Inborn (1) · Gram-Negative Bacterial Infections (1) · Gram-Positive Bacterial Infections (1)
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide (1)
Aridis Pharmaceuticals, Inc. (1) · Gilead Sciences (1) · RedHill Biopharma Limited (1)
Brazil (2) · Israel (2) · Mexico (2) · Russia (2) · United States (2) · Australia (1) · Belarus (1) · Belgium (1) · Canada (1) · China (1) · Colombia (1) · Estonia (1) · France (1) · Georgia (1) · Italy (1)
Claire Wainwright, MD (1) · Hasan S Jafri, MD, FAAP (1) · Mark L Levitt, MD (1) · Ron Gibson, MD (1)